Incepta Pharmaceutical Ltd. is the second largest pharmaceutical company in the country with a market share of 10.21% in the pharmaceutical industry of Bangladesh. It was founded in 1999 by Abdul Muktadir. The pharmaceutical company, established as a concern of Impress Group, has two more sister concerns Incepta Vaccine and Neocare. Insepta Pharmaceuticals’ products include capsules, tablets, nasal sprays, eye drops, and more than 600 generic drugs. The company also specializes in the preparation of medicines such as sustained-release tablets, quick-mouth dissolving tablets, effervescent tablets, and insulin.
Incepta and its sister concerns are currently manufacturing products such as human vaccines, monoclonal antibodies, biotech products, hormones, natural products, animal health products, hygiene products, and hospital devices. According to a January 2021 report in The Daily Star, Incepta Pharmaceutical has an annual turnover of BDT 2,755 crore.